COVID-19 Risks Linked to Medications in IBD
Multicenter and population cohort studies suggest that patients with inflammatory bowel disease are not at unique risk of contracting COVID-19 or experiencing worse outcomes, with a few exceptions. Medscape Medical News
Read The Rest
at : https://www.medscape.com/cx/rssfeeds/2700.xml
Major medical groups urge Americans to get COVID vaccine
Study shows young COVID survivors can get reinfected
Unusual 2019-2020 flu season linked to more transmissible...
COVID-19 health threat increases psychological distress...
No French Covid lockdown for now: PM
Surviving COVID-19 survivor's guilt
School gardens linked with kids eating more vegetables
Dialysis patients have four-fold greater risk of dying...
COVID-19 vaccine safe and effective in animal models
Study shows flu vaccine lessens COVID-19 symptoms in...
All Rights Reserved